The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 502.00
Bid: 500.00
Ask: 502.00
Change: 7.00 (1.41%)
Spread: 2.00 (0.40%)
Open: 492.00
High: 502.00
Low: 492.00
Prev. Close: 495.00
CRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

27 Jan 2012 07:00

RNS Number : 2733W
Creston PLC
27 January 2012
 



 

 

27 January 2012

 

 

Creston plc

Interim Management Statement

 

Creston plc ('Creston' or the 'Group') (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 October 2011 to date.

 

Trading update

 

For the three months to 31 December 2011 (the 'Period'), the Group reported revenue growth of over 22 per cent compared to the same period last year. Like-for-like1 revenue growth for the third quarter was 7 per cent, compared to the same period in the prior year. Year to date, like-for-like revenue growth of 5 per cent has been achieved.

 

Despite this revenue growth, the Board's expectation for Headline2 PBIT3 for the full year is lowered to be slightly below that of the prior year. The anticipated reduction in Headline PBIT is as a result of a shortfall in fourth quarter new business, the costs associated with staffing-up to service the expected increase in revenue, client projects being delayed until the new financial year and operating losses associated with the start-up ventures in the year. Appropriate actions have begun to align operating costs to the lower expected sales levels, the effects of which will predominantly be realised from the start of the new financial year.

 

Insight

 

The Insight division had a good third quarter growth in revenue, which exceeded the preceding second quarter as well as quarter three of the prior year. This growth has been achieved by the addition of new clients in the first half of the year, such as the BBC and others, which cannot currently be named. In the Period, the division established Vitaris, a new healthcare research consultancy, targeting new and existing health clients. This new product offering was launched later than expected and accordingly the contribution to the current financial year will be below original expectations. This business is expected to be margin accretive in the next financial year.

 

Although the Insight division's performance to date has shown positive revenue growth, the Board expects a revenue decline for the ICM business in the fourth quarter caused by a shortfall in new business and a delay of projects into the new financial year. This is disappointing considering the improving performance of the Insight division and the new client wins earlier in the year. The necessary actions are being taken to align operating costs to the lower expected level of sales for the remainder of this, and future financial years. However, the savings generated from actions already underway will have minimal impact in the current financial year and the revenue decline will have a direct impact on fourth quarter profitability.

 

Communications

 

The Communications division has continued its positive revenue growth in the third quarter versus the first half of the year and compared to the same period last year. This growth has been achieved due to the successful addition of new clients, such as Brother, Open University, Sue Ryder and the continued expansion of activity for existing clients, such as the successful addition to the Unilever European digital roster.

 

The growth in full year revenue for the Communications division is broadly in line with the Board's expectations, however, this incremental revenue will not fully convert to PBIT due to the slower than budgeted financial performance of the start-ups during the year, such as Creston Unlimited and the Nelson Bostock Group's public relations office in Hong Kong. Whilst such organic initiatives are generally loss making in their first year of trading, this strategy of investing in start-ups remains important to the long term growth of the division.

 

Health

 

TheHealth division has materially increased its revenue and PBIT in the third quarter versus the prior year, due to the growth of its presence in the US. The addition of the US public relations companies to the division has strengthened its global PR capability and as a consequence there are an increasing number of on-going global pitches, in addition to the recent World Hepatitis Alliance win.

 

Additionally, the division's new local health offer (launched as Grapevine in the second quarter) has already won its first client and is set to benefit from the Government's recent announcement to ring fence £5 billion for local government public health.

 

The decline however in new business opportunities announced in the first half of the year has had the expected impact on the third quarter with a small like-for-like revenue decline. While there has been an improvement in new business opportunities during the second half with some new client wins, this will not have as big an impact this financial year as was expected. In addition, fourth quarter delays to client budgets are also expected to push further revenue back into the next financial year.

 

Outlook

 

The Group has reported good like-for-like revenue growth of 7 per cent in the third quarter and although the full year like-for-like and reported revenue growth is expected to be positive, fourth quarter revenue will be lower than the Board's expectations. Despite this revenue growth, Headline PBIT is expected to be slightly below that of the prior year as detailed above. Since the Group's performance was weighted to the second half of the year and especially the fourth quarter, the cost reductions that have been implemented will have minimal impact on this financial year, but will improve profitability on future revenue.

 

 

 

 

 

For further information please contact:

 

Creston plc

+ 44 (0)20 7930 9757

Don Elgie, Group Chief Executive

Barrie Brien, COO/CFO

M:Communications

+44 (0)20 7920 2339

Elly Williamson

 

 

 

About Creston plc

Creston plc (LSE: CRE) is a marketing services company focused on insight-led communications. The Group delivers a range of marketing services, including digital marketing, market research, health communications, public relations, direct marketing, advertising and brand consultancy to a broad spectrum of blue-chip clients. All our companies share a common commitment to understanding, influencing and inspiring consumers on behalf of our clients and to creating value through innovative collaborative working. www.creston.com

 

 


1 Like-for-like compares current year performance to prior year performance, excluding the results from any acquisitions.

 

2 Headline results reflect the underlying performance of the Group and excludes acquisition, start-up and restructuring related costs, deemed remuneration charges and notional finance costs.

 

3 Profit before finance income, finance costs and taxation (PBIT).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAFFKADLAEAF
Date   Source Headline
25th Apr 20244:11 pmRNSHolding(s) in Company
19th Apr 20247:00 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSNotice of AGM
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
4th Apr 20243:52 pmRNSDirector/PDMR Shareholding
28th Mar 20243:53 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
12th Mar 20243:11 pmRNSHolding(s) in Company
7th Mar 20245:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20243:53 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 20244:48 pmRNSPurchase of Shares by Employee Benefit Trust
4th Mar 20243:58 pmRNSPurchase of Shares by Employee Benefit Trust
1st Mar 20244:00 pmRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20241:40 pmRNSAnnual Financial Report
28th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20247:00 amRNSHolding(s) in Company
26th Feb 20245:44 pmRNSPurchase of Shares by Employee Benefit Trust
26th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st Feb 20247:00 amRNSAppointment of Senior Independent Director
21st Feb 20247:00 amRNSPreliminary results for the year ended 31/12/2023
13th Feb 20247:00 amRNSNotice of Full Year 2023 Trading Update
29th Jan 20247:00 amRNSPerformance Update
25th Jan 20247:00 amRNSJanuary 2024 Trading Update
15th Jan 20247:00 amRNSNotice of 1 January 2024 Renewals Trading Update
14th Dec 20235:39 pmRNSDirector/PDMR Shareholding
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.